COMMUNIQUÉS West-GlobeNewswire
-
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
18/08/2026 -
Two physicians at The Wall Center named to America's Best Plastic Surgeons 2026 — a first for any Shreveport practice
18/08/2026 -
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026 -
Ketogenic Foundation Announces 2026 Conference Exploring the Future of Metabolic Health and Chronic Disease Care
18/08/2026 -
USAHS Celebrates 20,000 Degrees Amid Continued Growth and Program Expansion
18/08/2026 -
Trethera Appoints World-Renowned ALS Researcher Dr. Merit Cudkowicz to Scientific Advisory Board
18/08/2026 -
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t
18/08/2026 -
Jabra Enhance introduces a new lineup of FDA-cleared self-fitting hearing aids, 3 new models with improved hearing technology and in-app self-tuning
18/08/2026 -
Direct Meds Updates DirectMax Clinical Review and Licensed-Pharmacy Fulfillment Details (2026)
18/08/2026 -
FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
18/08/2026 -
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
18/08/2026 -
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
18/08/2026 -
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
18/08/2026 -
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
18/08/2026 -
BrewDog Unwraps Its 2026 Advent Calendar
18/08/2026 -
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
18/08/2026 -
PROMIXX Pursuit Insulated Shaker Bottle Keeps Protein Shakes Ice Cold for 12+ Hours, Outlasting Standard Gym Bottles
18/08/2026 -
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
18/08/2026 -
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
18/08/2026
Pages